Sector

Healthcare

One of the most prominent practices in Europe, on a growing resilient sector, underpinned by constant innovation in biotech and medtech, and long-term demand for healthcare services.

Bryan, Garnier & Co's insights and news

Read the latest news, reports and newsletters from Europe’s Growth Investment Bank to find out more about current trends impacting investment banking activity and company performance.

Healthcare transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co has successfully advised majority shareholder GRED in the public tender offer & squeeze out of Softway Medical

Softway Medical tombstone

Bryan, Garnier & Co. announces it has advised ExonHit Therapeutics on the free allocation of subscription warrants to all its shareholders

ExonHit Therapeutics 2008 tombstone

Bryan, Garnier & Co. announces successful admission of ONI BioPharma Inc.’s common stock to listing and trading on NYSE Alternext Paris

ONI BioPharma tombstone

Bryan, Garnier & Co successfully advised Pierrel on its EUR 17.1 million follow-on offering

Pierrel tombstone

Bryan Garnier successfully leads €12 million IPO for Ipsogen

Ipsogen tombstone

Bryan, Garnier & Co. successfully completes the placement of the international tranche of Arkimedica’s € 28 million convertible bond

Arkimedica tombstone

Bryan, Garnier & Co advised Plethico Pharmaceuticals Limited on its acquisition of Natrol, Inc.

Natrol_website_tombstone

Bryan, Garnier & Co successfully leads a €40 million private placement in public equity for BioAlliance

BioAlliance tombstone

Bryan, Garnier & Co successfully leads a €100.1 million capital increase for Transgene

Transgene 2007 tombstone

Bryan, Garnier & Co successfully leads a €33.7 million IPO for Innate Pharma

Innate Pharma 2006 tombstone

Bryan, Garnier & Co leads a 11,5 million IPO for MEDICREA on Alternext

MEDICREA tombstone

Bryan, Garnier & Co & ING announce the successful completion of BioAlliance Pharma (Eurolist Paris : FR0010095596) EUR 30 m Initial Public Offering

BioAlliance Pharma 2005 tombstone

Bryan, Garnier & Co, the European Growth investment bank successfully led the the secondary placement of a EUR 13M holding of 21 Investimenti in Stedim, a Euronext-listed company

Stedim tombstone

Bryan, Garnier & Co Leads a EUR 34,9 M follow-on offering of Ordinary Shares with Warrants (ABSA) from Leading International Institutional Investors for Transgene (Eurolist Paris : FR0005175080)

Transgene 2005 tombstone

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }